Detected ·
Alchemab Therapeutics Ltd
£25M—
Alchemab Therapeutics secured £25M Series A extension from British Business Bank, bringing total Series A to £109M. The biotech will expand its proprietary antibody database to 1B sequences and advance clinical pipeline.
- Website
- www.alchemab.com
- Amount
- £25 000 000 GBP
- Stage
- —
- Event
- Funding round
- Detected
- 2026-07-09 12:09:48 UTC
- Signal ID
- 64af29a4-050c-4436-a1b7-13d7ad34218f
As the API returns it
{
"id": "64af29a4-050c-4436-a1b7-13d7ad34218f",
"created_at": "2026-07-09T12:09:48.373197Z",
"company_name": "Alchemab Therapeutics Ltd",
"company_website_url": "www.alchemab.com",
"company_linkedin_url": "https://www.linkedin.com/company/alchemab-therapeutics-ltd",
"event_type": "funding",
"funding_amount": 25000000,
"funding_currency": "GBP",
"funding_stage": null,
"message": "*Alchemab Therapeutics secured £25M Series A extension from British Business Bank, bringing total Series A to £109M. The biotech will expand its proprietary antibody database to 1B sequences and advance clinical pipeline.*"
}